1. Home
  2. RLAY vs UVSP Comparison

RLAY vs UVSP Comparison

Compare RLAY & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • UVSP
  • Stock Information
  • Founded
  • RLAY 2015
  • UVSP 1876
  • Country
  • RLAY United States
  • UVSP United States
  • Employees
  • RLAY N/A
  • UVSP N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • UVSP Major Banks
  • Sector
  • RLAY Health Care
  • UVSP Finance
  • Exchange
  • RLAY Nasdaq
  • UVSP Nasdaq
  • Market Cap
  • RLAY 803.4M
  • UVSP 910.5M
  • IPO Year
  • RLAY 2020
  • UVSP 1989
  • Fundamental
  • Price
  • RLAY $6.72
  • UVSP $29.48
  • Analyst Decision
  • RLAY Strong Buy
  • UVSP Hold
  • Analyst Count
  • RLAY 8
  • UVSP 3
  • Target Price
  • RLAY $17.25
  • UVSP $30.67
  • AVG Volume (30 Days)
  • RLAY 2.0M
  • UVSP 87.9K
  • Earning Date
  • RLAY 11-06-2025
  • UVSP 10-22-2025
  • Dividend Yield
  • RLAY N/A
  • UVSP 3.00%
  • EPS Growth
  • RLAY N/A
  • UVSP 19.65
  • EPS
  • RLAY N/A
  • UVSP 2.98
  • Revenue
  • RLAY $8,355,000.00
  • UVSP $309,144,000.00
  • Revenue This Year
  • RLAY $27.30
  • UVSP $12.42
  • Revenue Next Year
  • RLAY $7.43
  • UVSP $4.67
  • P/E Ratio
  • RLAY N/A
  • UVSP $9.85
  • Revenue Growth
  • RLAY N/A
  • UVSP 7.22
  • 52 Week Low
  • RLAY $1.78
  • UVSP $22.83
  • 52 Week High
  • RLAY $7.64
  • UVSP $32.86
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 55.13
  • UVSP 46.82
  • Support Level
  • RLAY $6.64
  • UVSP $28.77
  • Resistance Level
  • RLAY $7.42
  • UVSP $29.56
  • Average True Range (ATR)
  • RLAY 0.43
  • UVSP 0.88
  • MACD
  • RLAY -0.11
  • UVSP 0.00
  • Stochastic Oscillator
  • RLAY 30.97
  • UVSP 43.59

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

Share on Social Networks: